NO307516B1 - FremgangsmÕte for fremstilling av et tetrazolderivat i to krystallinske former og ny krystallinsk form av nevnte derivat - Google Patents

FremgangsmÕte for fremstilling av et tetrazolderivat i to krystallinske former og ny krystallinsk form av nevnte derivat

Info

Publication number: NO307516B1
Authority: NO; Norway
Prior art keywords: derivative; water; ray diffraction; diffraction pattern; contg
Prior art date: 1994-10-19

Application number

NO954154A

Other languages

English (en)

Other versions

NO954154D0 (no

NO954154L (no

Inventor

Antoine Caron

Dominique Chantreux

Colette Bouloumie

Original Assignee

Sanofi Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-10-19

Filing date

1995-10-18

Publication date

2000-04-17

1995-10-18 Application filed by Sanofi Sa filed Critical Sanofi Sa

1995-10-18 Publication of NO954154D0 publication Critical patent/NO954154D0/no

1996-04-22 Publication of NO954154L publication Critical patent/NO954154L/no

2000-04-17 Publication of NO307516B1 publication Critical patent/NO307516B1/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Photoreceptors In Electrophotography (AREA)

NO954154A 1994-10-19 1995-10-18 FremgangsmÕte for fremstilling av et tetrazolderivat i to krystallinske former og ny krystallinsk form av nevnte derivat NO307516B1 (no)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR9412459A FR2725987B1 (fr)	1994-10-19	1994-10-19	Procede pour la preparation d'un derive de tetrazole sous deux formes cristallines et nouvelle forme cristalline de ce derive

Publications (3)

Publication Number	Publication Date
NO954154D0 NO954154D0 (no)	1995-10-18
NO954154L NO954154L (no)	1996-04-22
NO307516B1 true NO307516B1 (no)	2000-04-17

Family

ID=9467986

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO954154A NO307516B1 (no)	1994-10-19	1995-10-18	FremgangsmÕte for fremstilling av et tetrazolderivat i to krystallinske former og ny krystallinsk form av nevnte derivat

Country Status (27)

Country	Link
US (1)	US5629331A (no)
EP (1)	EP0708103B1 (no)
JP (1)	JP3366786B2 (no)
KR (1)	KR100251222B1 (no)
CN (1)	CN1061656C (no)
AT (1)	ATE198478T1 (no)
AU (1)	AU698041B2 (no)
CA (1)	CA2160725C (no)
CY (1)	CY2277B1 (no)
CZ (2)	CZ288629B6 (no)
DE (1)	DE69519788T2 (no)
DK (1)	DK0708103T3 (no)
ES (1)	ES2155115T3 (no)
FI (1)	FI114156B (no)
FR (1)	FR2725987B1 (no)
GR (1)	GR3035503T3 (no)
HK (1)	HK1005135A1 (no)
HU (1)	HU226461B1 (no)
IL (1)	IL115688A (no)
NO (1)	NO307516B1 (no)
NZ (1)	NZ280293A (no)
PL (1)	PL184193B1 (no)
PT (1)	PT708103E (no)
RU (1)	RU2144536C1 (no)
SI (1)	SI0708103T1 (no)
TW (1)	TW357147B (no)
ZA (1)	ZA958850B (no)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5994348A (en)	1995-06-07	1999-11-30	Sanofi	Pharmaceutical compositions containing irbesartan
TW442301B (en) *	1995-06-07	2001-06-23	Sanofi Synthelabo	Pharmaceutical compositions containing irbesartan
FR2780403B3 (fr) *	1998-06-24	2000-07-21	Sanofi Sa	Nouvelle forme de l'irbesartan, procedes pour obtenir ladite forme et compositions pharmaceutiques en contenant
SK18822000A3 (sk)	1998-07-06	2001-12-03	Bristol-Myers Squibb Company	Bifenylsulfónamidy ako duálne antagonisty angiotenzínového a endotelínového receptora
CA2469656A1 (en) *	2001-12-10	2003-06-19	Dr. Reddy's Laboratories Limited	Amorphous form of 2-n-butyl-3-( (2-(1h-tetrazol-5-yl) (1,1'-biphenyl)-4-yl) methyl) -1,3-diazaspiro (4,4') non-1-en-4-one
CA2492779A1 (en) *	2002-07-16	2004-01-22	Teva Pharmaceutical Industries Ltd	Novel synthesis of irbesartan
ES2281312T3 (es) *	2003-01-16	2008-08-01	Teva Pharmaceutical Industries Ltd.	Nueva sintesis de irbesartan.
EP1590343B1 (en) *	2003-02-05	2008-07-16	Teva Pharmaceutical Industries Limited	Synthesis of 2-butyl-3-(2' -(1-trityl-1h-tetrazol-5-yl)biphen yl-4-yl)-1,3-diazaspiro-4,4 -nonene-4-one
AU2003242984A1 (en) *	2003-04-07	2004-11-01	Hetero Drugs Limited	A novel crystalline form of irbesartan
WO2005051943A1 (en) *	2003-11-28	2005-06-09	Ranbaxy Laboratories Limited	Processes for the preparation of highly pure irbesartan
ES2282062T1 (es)	2004-06-04	2007-10-16	Teva Pharmaceutical Industries Ltd.	Composicion farmaceutica que contiene irbesartan.
WO2006001026A1 (en) *	2004-06-23	2006-01-05	Hetero Drugs Limited	Irbesartan polymorphs
SI21849A (sl) *	2004-07-29	2006-02-28	Krka, Tovarna Zdravil, D.D., Novo Mesto	Priprava hidrokloridnih soli tetrazolskega derivata
TWI346108B (en)	2004-08-23	2011-08-01	Bristol Myers Squibb Co	A method for preparing irbesartan and intermediates thereof
GB2419592A (en) *	2004-10-26	2006-05-03	Cipla Ltd	Process for the preparation of irbesartan hydrochloride
SI1812422T1 (sl) *	2004-11-11	2014-05-30	Lek Pharmaceuticals D.D.	Kristalna oblika irbesartana
ES2259909B1 (es) *	2005-02-28	2007-06-16	Inke, S.A.	Procedimiento para la obtencion de un compuesto farmaceuticamente activo y de su intermedio de sintesis.
US7964737B2 (en)	2005-07-27	2011-06-21	Jubilant Organosys Limited	Process for producing 2-(n-butyl)-3-[[2′-(tetrazol-5-yl)biphenyl-4-yl]methyl]-1,3-diazaspiro[4.4] non-1-en-4-one
ES2340701T3 (es)	2006-01-09	2010-06-08	Krka, D.D., Novo Mesto	Composicion farmaceutica solida que comprende irbesartan.
WO2008041957A1 (en) *	2006-10-03	2008-04-10	Ulkar Kimya Sanayi Ve Ticaret As	Method for producing pure crystalline form of 2-n-butyl-3-((2-(1h-tetrazole-5-yl) (1,1'-biphenyl)-4-methyl)-1,3-diazapspiro (4,4') non -1- en-4-one
EP1918288A1 (en)	2006-11-02	2008-05-07	Cadila Pharmaceuticals Limited	A novel and improved process for the preparation of Irbesartan, an angiotensin-II receptor antagonist for the treatment of hypertension
EP2065035B1 (en)	2007-11-28	2010-07-21	Laboratorios Lesvi, S.L.	Pharmaceutical formulations containing irbesartan
EP2215083A2 (en) *	2007-12-07	2010-08-11	Hetero Drugs Limited	Process for pure irbesartan
KR101009383B1 (ko) *	2008-04-30	2011-01-19	켐젠주식회사	고순도의2-부틸-3-[[2'-(1에이취-테트라졸-5-일)[1,1'-비페닐]-4-일]메틸]-1,3-디아자스피로[4.4]논-1-엔-4-온 화합물의제조방법
WO2010116380A2 (en) *	2009-04-08	2010-10-14	Ctx Life Sciences Pvt. Ltd.	A one pot process for preparing 2-butyl-3-[[2'-(1h-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1,3-diazaspiro [4, 4] non-1-en-4-one (irbesartan)
AR078107A1 (es) *	2009-08-31	2011-10-12	Sanofi Aventis	Uso de irbesartan para la preparacion de un medicamento para la prevencion de la hospitalizacion por insuficiencia cardiaca
US8080670B2 (en)	2010-05-04	2011-12-20	Divi's Laboratories, Ltd.	Process for the preparation of irbesartan
FR2977253B1 (fr)	2011-06-30	2013-08-09	Centre Nat Rech Scient	Reactif organostannique alcoxyle supporte, preparation et utilisation pour la synthese de tetrazoles en phase heterogene
WO2018002673A1 (en)	2016-07-01	2018-01-04	N4 Pharma Uk Limited	Novel formulations of angiotensin ii receptor antagonists
US11655220B2 (en)	2020-10-22	2023-05-23	Hetero Labs Limited	Process for the preparation of angiotensin II receptor blockers
EP4408836A1 (en)	2021-10-01	2024-08-07	Sanofi	Process for preparing sartan active compounds having a tetrazole ring

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2697919B2 (ja) *	1989-09-29	1998-01-19	キヤノン株式会社	信号内挿回路及び該回路を備えた変位測定装置
IE70593B1 (en) *	1989-09-29	1996-12-11	Eisai Co Ltd	Biphenylmethane derivative the use of it and pharmacological compositions containing same
IL99372A0 (en) *	1990-09-10	1992-08-18	Ciba Geigy Ag	Azacyclic compounds

1994
- 1994-10-19 FR FR9412459A patent/FR2725987B1/fr not_active Expired - Fee Related
1995
- 1995-10-17 CA CA002160725A patent/CA2160725C/en not_active Expired - Fee Related
- 1995-10-17 CZ CZ19952710A patent/CZ288629B6/cs not_active IP Right Cessation
- 1995-10-17 US US08/544,027 patent/US5629331A/en not_active Expired - Lifetime
- 1995-10-18 CN CN95118711A patent/CN1061656C/zh not_active Expired - Lifetime
- 1995-10-18 DK DK95402322T patent/DK0708103T3/da active
- 1995-10-18 NO NO954154A patent/NO307516B1/no not_active IP Right Cessation
- 1995-10-18 AT AT95402322T patent/ATE198478T1/de active
- 1995-10-18 RU RU95118109/04A patent/RU2144536C1/ru active
- 1995-10-18 TW TW084110953A patent/TW357147B/zh not_active IP Right Cessation
- 1995-10-18 SI SI9530469T patent/SI0708103T1/xx unknown
- 1995-10-18 EP EP95402322A patent/EP0708103B1/fr not_active Expired - Lifetime
- 1995-10-18 PL PL95311012A patent/PL184193B1/pl not_active IP Right Cessation
- 1995-10-18 PT PT95402322T patent/PT708103E/pt unknown
- 1995-10-18 ES ES95402322T patent/ES2155115T3/es not_active Expired - Lifetime
- 1995-10-18 DE DE69519788T patent/DE69519788T2/de not_active Expired - Lifetime
- 1995-10-19 IL IL11568895A patent/IL115688A/xx not_active IP Right Cessation
- 1995-10-19 FI FI954992A patent/FI114156B/fi not_active IP Right Cessation
- 1995-10-19 ZA ZA958850A patent/ZA958850B/xx unknown
- 1995-10-19 HU HU9503016A patent/HU226461B1/hu unknown
- 1995-10-19 AU AU34335/95A patent/AU698041B2/en not_active Ceased
- 1995-10-19 KR KR1019950036285A patent/KR100251222B1/ko not_active IP Right Cessation
- 1995-10-19 JP JP27151295A patent/JP3366786B2/ja not_active Expired - Lifetime
- 1995-10-19 NZ NZ280293A patent/NZ280293A/en not_active IP Right Cessation
1998
- 1998-05-19 HK HK98104339A patent/HK1005135A1/xx not_active IP Right Cessation
2000
- 2000-07-07 CZ CZ20002544A patent/CZ288624B6/cs not_active IP Right Cessation
2001
- 2001-03-05 GR GR20010400343T patent/GR3035503T3/el unknown
2002
- 2002-05-15 CY CY0200030A patent/CY2277B1/xx unknown

Also Published As

Publication number	Publication date
GR3035503T3 (en)	2001-06-29
CA2160725C (en)	2001-12-18
CZ288624B6 (cs)	2001-08-15
IL115688A (en)	1999-09-22
KR100251222B1 (ko)	2000-05-01
RU2144536C1 (ru)	2000-01-20
FI954992A0 (fi)	1995-10-19
DK0708103T3 (da)	2001-04-23
CZ288629B6 (cs)	2001-08-15
PT708103E (pt)	2001-06-29
TW357147B (en)	1999-05-01
CN1061656C (zh)	2001-02-07
US5629331A (en)	1997-05-13
PL184193B1 (pl)	2002-09-30
CY2277B1 (en)	2003-07-04
FR2725987B1 (fr)	1997-01-10
FI954992A (fi)	1996-04-20
CN1128261A (zh)	1996-08-07
HU9503016D0 (en)	1995-12-28
HK1005135A1 (en)	1998-12-24
HUT73179A (en)	1996-06-28
KR960014122A (ko)	1996-05-22
ATE198478T1 (de)	2001-01-15
EP0708103A1 (fr)	1996-04-24
NO954154D0 (no)	1995-10-18
CA2160725A1 (en)	1996-04-20
JP3366786B2 (ja)	2003-01-14
DE69519788T2 (de)	2001-08-30
JPH08208642A (ja)	1996-08-13
HU226461B1 (en)	2008-12-29
NZ280293A (en)	1997-10-24
FI114156B (fi)	2004-08-31
ES2155115T3 (es)	2001-05-01
DE69519788D1 (de)	2001-02-08
ZA958850B (en)	1996-05-27
AU3433595A (en)	1996-05-02
SI0708103T1 (en)	2001-04-30
AU698041B2 (en)	1998-10-22
FR2725987A1 (fr)	1996-04-26
IL115688A0 (en)	1996-01-19
PL311012A1 (en)	1996-04-29
NO954154L (no)	1996-04-22
CZ271095A3 (en)	1996-05-15
EP0708103B1 (fr)	2001-01-03

Publication	Publication Date	Title
NO307516B1 (no)	2000-04-17	FremgangsmÕte for fremstilling av et tetrazolderivat i to krystallinske former og ny krystallinsk form av nevnte derivat
RU95118109A (ru)	1997-09-20	Способ получения производного тетразола, способ получения формы b производного тетразола, форма b производного тетразола и фармацевтическая композиция на основе производного тетразола формы b
ATE235471T1 (de)	2003-04-15	Neue benzylpyrimidine
NO973813L (no)	1997-11-03	Fremgangsmåte ved gjenvinning av xylose fra opplösninger
CA2229000A1 (en)	1992-08-22	1-biphenylimidazole derivatives, their preparation and their therapeutic use
ATE240323T1 (de)	2003-05-15	Heterozyklische verbindungen, verfahren zu deren herstellung und deren anwendung als angiotensin- ii-antagonist
PT865281E (pt)	2002-09-30	Derivados de benzimidazole substituidos por naftilo como anticoagulantes
NO941857D0 (no)	1994-05-18	Tetrazolylfenylborsyremellomprodukter for syntese av AII-reseptorantagonister
DE69333489D1 (de)	2004-05-19	Heterocyclische Verbindungen und ihre Verwendung als Angiotensin II Antagonisten
CA2353680C (en)	2008-09-09	Process for the production of cyclene
US6156890A (en)	2000-12-05	Process for the production of cyclene
PL339641A1 (en)	2000-10-23	Method of obtaining pyridinole hydrochloride
JPH0673051A (ja)	1994-03-15	ベンズアゾール誘導体
ES2179959T3 (es)	2003-02-01	Procedimiento de preparacion de 4'-demetilepipodofilotoxina a partir de podofilotoxina.
Jubault et al.	1993	Selective electroreduction of substituted 1, 3-thiazinic compounds
FI943730A (fi)	1994-08-12	Menetelmä angiotensiini-II-antagonistina aktiivisen 3-(2'-N-bentsoyylisulfonamido-bifen-4-yyli)metyyli-5,7-dimetyyli-2-etyyli-3H-imidatso/4,5-b/pyridiinin valmistamiseksi
CA2081135A1 (en)	1993-05-26	Method for precipitating an organic resin from an alkaline solution thereof

Legal Events

Date	Code	Title	Description
2015-05-26	MM1K	Lapsed by not paying the annual fees